High effector-memory CD8+ T-cell levels correlate with high PML risk in natalizumab-treated patients
Beldi-Ferchiou, Asma, Wahab, Abir, Duchmann, Matthieu, Hodel, Jérôme, Patry, Ivania, Delfau-Larue, Marie-Hélène, Molinier-Frenkel, Valérie, Créange, AlainVolume:
46
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2020.102470
Date:
November, 2020
File:
PDF, 4.19 MB
2020